PMV Pharmaceuticals And Chiromics Announce Licensing Agreement And Drug Discovery Collaboration
2/25/2014 9:38:47 AM
DOYLESTOWN, Pa. & PRINCETON, N.J.--(BUSINESS WIRE)--PMV Pharmaceuticals, Inc., and Chiromics LLC today announced that they have entered into a collaboration whereby PMV Pharma has a non-exclusive license for use of Chiromics’ chemical compound library and a screening collaboration to discover and optimize novel small molecules against multiple PMV oncology and infectious disease therapeutic targets.
Help employers find you! Check out all the jobs and post your resume.
comments powered by